Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Revenue

In the year 2025, Tonix Pharmaceuticals Holding had annual revenue of $13.11M with 29.85% growth. Tonix Pharmaceuticals Holding had revenue of $5.39M in the quarter ending December 31, 2025, with 108.75% growth.

• Revenue (ttm): $13.11M
• Revenue Growth: +29.85%
• P/S Ratio: 13.17
• Revenue / Employee: $92,303
• Employees: 142
• Market Cap: 172.66M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.11M	3.01M	29.85%
Dec 31, 2024	10.09M	2.33M	29.94%
Dec 31, 2023	7.77M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-